- Investing Ideas
- /
- Hong Kong Healthcare Undervalued Stocks Based On Cash Flows
Hong Kong Healthcare Undervalued Stocks Based On Cash Flows
Results
5
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
5 companies
Beijing Chunlizhengda Medical Instruments
Market Cap: HK$5.1b
Beijing Chunlizhengda Medical Instruments Co., Ltd.
1858
HK$9.05
7D
0.9%
1Y
-14.6%
MicroPort NeuroScientific
Market Cap: HK$5.9b
Engages in the research and development, production, and sale of neuro-interventional medical devices in the People’s Republic of China and internationally.
2172
HK$10.30
7D
2.0%
1Y
19.8%
MicroPort Scientific
Market Cap: HK$12.5b
An investment holding company, engages in the manufacture, marketing, and sale of medical devices in the People’s Republic of China, North America, Europe, rest of Asia, South America, and internationally.
853
HK$6.77
7D
-1.7%
1Y
20.7%
Angelalign Technology
Market Cap: HK$8.3b
An investment holding company, researches and develops, designs, manufactures, and markets clear aligner treatment solutions in the People’s Republic of China.
6699
HK$48.95
7D
0.6%
1Y
-34.1%
Shanghai Conant Optical
Market Cap: HK$11.3b
Manufactures and sells resin spectacle lenses in Mainland China, the Americas, Asia, Europe, Oceania, and Africa.
2276
HK$23.45
7D
0%
1Y
193.1%